Cargando…
Discrepancies between preliminary and final COVID-19 mortality data—the case of Serbia
PURPOSE: Since the start of the COVID-19 pandemic, countries have scrambled to set up data collection and dissemination pipelines for various online datasets. This study aims to evaluate the reliability of the preliminary COVID-19 mortality data from Serbia, which has been included in major COVID-19...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184866/ https://www.ncbi.nlm.nih.gov/pubmed/37196849 http://dx.doi.org/10.1016/j.annepidem.2023.05.006 |
_version_ | 1785042227122143232 |
---|---|
author | Galjak, Marko Marinković, Ivan |
author_facet | Galjak, Marko Marinković, Ivan |
author_sort | Galjak, Marko |
collection | PubMed |
description | PURPOSE: Since the start of the COVID-19 pandemic, countries have scrambled to set up data collection and dissemination pipelines for various online datasets. This study aims to evaluate the reliability of the preliminary COVID-19 mortality data from Serbia, which has been included in major COVID-19 databases and utilized for research purposes worldwide. METHODS: Discrepancies between the preliminary mortality data and the final mortality data in Serbia were analyzed. The preliminary data were reported through an emergency-necessitated system, while the final data were generated by the regular vital statistics pipeline. We identified databases that include these data and conducted a literature review of articles that utilized them. RESULTS: The number of deaths due to COVID-19 in Serbia, as reported preliminarily, does not align with the final death toll, which is more than three times higher. Our literature review identified at least 86 studies that were impacted by these problematic data. CONCLUSIONS: We strongly advise researchers to disregard the preliminary COVID-19 mortality data from Serbia due to the significant discrepancies with the final data. We recommend validating any preliminary data using excess mortality if all-cause mortality data are available. |
format | Online Article Text |
id | pubmed-10184866 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101848662023-05-16 Discrepancies between preliminary and final COVID-19 mortality data—the case of Serbia Galjak, Marko Marinković, Ivan Ann Epidemiol Original Article PURPOSE: Since the start of the COVID-19 pandemic, countries have scrambled to set up data collection and dissemination pipelines for various online datasets. This study aims to evaluate the reliability of the preliminary COVID-19 mortality data from Serbia, which has been included in major COVID-19 databases and utilized for research purposes worldwide. METHODS: Discrepancies between the preliminary mortality data and the final mortality data in Serbia were analyzed. The preliminary data were reported through an emergency-necessitated system, while the final data were generated by the regular vital statistics pipeline. We identified databases that include these data and conducted a literature review of articles that utilized them. RESULTS: The number of deaths due to COVID-19 in Serbia, as reported preliminarily, does not align with the final death toll, which is more than three times higher. Our literature review identified at least 86 studies that were impacted by these problematic data. CONCLUSIONS: We strongly advise researchers to disregard the preliminary COVID-19 mortality data from Serbia due to the significant discrepancies with the final data. We recommend validating any preliminary data using excess mortality if all-cause mortality data are available. Elsevier Inc. 2023-08 2023-05-15 /pmc/articles/PMC10184866/ /pubmed/37196849 http://dx.doi.org/10.1016/j.annepidem.2023.05.006 Text en © 2023 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Galjak, Marko Marinković, Ivan Discrepancies between preliminary and final COVID-19 mortality data—the case of Serbia |
title | Discrepancies between preliminary and final COVID-19 mortality data—the case of Serbia |
title_full | Discrepancies between preliminary and final COVID-19 mortality data—the case of Serbia |
title_fullStr | Discrepancies between preliminary and final COVID-19 mortality data—the case of Serbia |
title_full_unstemmed | Discrepancies between preliminary and final COVID-19 mortality data—the case of Serbia |
title_short | Discrepancies between preliminary and final COVID-19 mortality data—the case of Serbia |
title_sort | discrepancies between preliminary and final covid-19 mortality data—the case of serbia |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184866/ https://www.ncbi.nlm.nih.gov/pubmed/37196849 http://dx.doi.org/10.1016/j.annepidem.2023.05.006 |
work_keys_str_mv | AT galjakmarko discrepanciesbetweenpreliminaryandfinalcovid19mortalitydatathecaseofserbia AT marinkovicivan discrepanciesbetweenpreliminaryandfinalcovid19mortalitydatathecaseofserbia |